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Abstract g-Conotoxin MVIIC (MVIIC) blocks P/Q-type
calcium channels with high affinity and N-type calcium channels
with low affinity, while the highly homologous g-conotoxin
MVIIA blocks only N-type calcium channels. We wished to
obtain MVIIC analogues more selective for P/Q-type calcium
channels than MVIIC to elucidate structural differences among
the channels, which discriminate the g-conotoxins. To prepare a
number of MVIIC analogues efficiently, we developed a
combinatorial method which includes a random air oxidation
step. Forty-seven analogues were prepared in six runs and some
of them exhibited higher selectivity for P/Q-type calcium
channels than MVIIC in binding assays.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
Voltage-sensitive calcium channels control various biologi-
cal processes such as neurotransmitter release and muscle con-
traction, and are classi¢ed on the basis of electrophysiological
properties as L-, N-, P/Q-, R-, or T-type calcium channels [1].
While their molecular basis has been established in terms of
diversity of the K1 subunit [2], the contribution of each chan-
nel to a total calcium current is often dissected pharmacolog-
ically by using speci¢c blockers. g-Conotoxins, derived from
the venom of marine Conus snails, are one of the most prom-
inent among various classes of blockers, particularly for
blocking of N- and P/Q-type calcium channels [3]. g-Cono-
toxin GVIA and g-conotoxin MVIIA bind to N-type chan-
nels and g-conotoxin MVIIC binds to P/Q-type channels with
high a⁄nity and to N-type channels with low a⁄nity. The N-
and P/Q-type calcium channels regulate neurotransmitter re-
lease in presynaptic nerve terminals and play distinct roles in
the nervous system, so that discrimination of these channels
by the use of g-conotoxins is important for understanding
their contribution.
The three-dimensional structures of GVIA [4^7], MVIIA
[8^10], and MVIIC [11,12] have been studied by nuclear mag-
netic resonance (NMR) analysis, revealing that these conotox-
ins have the same structural motif. The key residues for bind-
ing were identi¢ed as Tyr13 and Lys2 as a result of single Ala
substitutions [13^18], but the determinants of the speci¢city
have not been elucidated so far. The fact that MVIIC, which
has a high sequence similarity to MVIIA, bind to P/Q-type
channels more e⁄ciently than to N-type channels indicates
that MVIIC can be used as a promising tool to elucidate
structural di¡erences in the pore-forming region between N-
type and P/Q-type channels [19,20].
Di⁄culty in preparing MVIIC analogues has been an ob-
stacle to the thorough investigation of structure^activity rela-
tionships, so that e¡ective methods for preparing many ana-
logues are required. In this study we tried to prepare a
number of MVIIC analogues at the same time by means of
a combinatorial method, aiming to obtain an MVIIC ana-
logue with improved speci¢city for P/Q-type channels. Linear
precursors of MVIIC analogues were synthesized on a peptide
synthesizer using cartridges which contained a mixture of
9-£uorenylmethoxycarbonyl (Fmoc)-amino acids and then
subjected to random air oxidation. The resultant crude ana-
logues were separated and puri¢ed by successive chromatog-
raphies. Forty-seven analogues were successfully prepared in
six runs and some of them exhibited high a⁄nity and selec-
tivity for P/Q-type calcium channels.
2. Materials and methods
2.1. Materials
Fmoc-amino acids, Fmoc-amide-resin, and other reagents used on a
synthesizer were obtained from Perkin-Elmer Applied Biosystems Ja-
pan (Chiba, Japan). [125I]GVIA and [125I]MVIIC were purchased
from NEN (Boston, MA, USA).
2.2. Synthesis and puri¢cation of peptides
Solid phase peptide synthesis was conducted on a Perkin-Elmer
Applied Biosystems 433A peptide synthesizer. Matrix-assisted laser
desorption/ionization time-of-£ight mass spectrometry (MALDI-
TOF-MS) was measured on a PerSeptive Biosystems Voyager Linear
DE mass spectrometer using K-cyano-4-hydroxycinnamic acid as a
matrix. Analytical HPLC was conducted on a Shimadzu LC-6A sys-
tem with an octadecylsilane (ODS) column (4.6U250 mm). Prepara-
tive HPLC was performed with a Shimadzu LC-8A system with an
ODS column (20U250 mm).
Fmoc-amino acids to be introduced into a substitution site were
packed into a regular cartridge in equimolar amounts such that the
sum of them was the appropriate amount based on the program. The
other steps of synthesis and puri¢cation were performed in the same
way as described previously for preparation of MVIIC analogues [19].
Brie£y, linear precursors of MVIIC analogues assembled by normal
operation of Fmoc solid-phase synthesis were deprotected and sub-
jected to air oxidation. The oxidized peptides were concentrated on an
ODS column with a medium-pressure pump, and then the monomeric
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peptides were isolated from the crude peptides by chromatography
with Sephadex G-50F and separated into fractions by chromatogra-
phy on CM-cellulose CM-52. The analogue was ¢nally puri¢ed from
each fraction by preparative HPLC with an ODS column and identi-
¢ed by MALDI-TOF-MS measurement. Among the obtained ana-
logues, analogue 34 (in Table 1) was resynthesized on a larger scale
for spectroscopic analysis.
2.3. Binding assay
Rat cerebellar P2 membranes were prepared as previously described
[21], and ¢lter binding assays were performed according to the pre-
vious method with some modi¢cations. For competition with GVIA,
the analogue and [125I]GVIA were incubated at 4‡C for 1.5 h with P2
membranes (10 Wg) in 50 Wl of 25 mM Tris^HEPES bu¡er (pH 7.4)
containing 0.04% bovine serum albumin (BSA). The mixture was
diluted with ice-cold 0.8 mM Tris^HEPES bu¡er containing 0.16 M
choline chloride and 0.1% BSA and then rapidly ¢ltered under vac-
uum with a GF/C ¢lter (Whatman) soaked in the same bu¡er. The
¢lter was washed with the ice-cold bu¡er twice and its radioactivity
was measured with a Q-counter. For competition with MVIIC, the
analogue and [125I]MVIIC were incubated at 4‡C for 1.5 h with P2
membranes (10 Wg) in 50 Wl Tris-bu¡ered saline: 150 mM NaCl,
25 mM Tris^HCl adjusted to pH 7.4 (TBS), containing 0.1% BSA.
The mixture was diluted with ice-cold TBS containing 1.5 mM CaCl2,
0.1% BSA, and 0.05% Tween-20 and then rapidly ¢ltered under vac-
uum with a GF/C ¢lter pre-treated with 0.03% polyethyleneimine. The
Table 1
Numbers, yields, and e¡ects on radioligand binding of MVIIC and its analogues
Run No. Peptidea Yield (%)b Radioligand binding (%)c
GVIA MVIIC
1 1 MVIIC 6.4 20 þ 3 18 þ 3
2 K2Q 3.0 46 þ 8 61 þ 9
3 M12T 0.5 17 þ 0 66 þ 8
4 M12Y 1.7 22 þ 2 39 þ 6
5 Y13W 4.4 101 þ 4 47 þ 4
6 K2Q, M12T 0.9 94 þ 4 82 þ 4
7 K2Q, M12Y 2.6 98 þ 1 69 þ 2
8 K2Q, Y13W 3.7 102 þ 4 89 þ 8
9 M12T, Y13W 0.9 99 þ 6 101 þ 7
10 M12Y, Y13W 2.0 98 þ 3 66 þ 4
11 K2Q, M12Y, Y13W 1.9 100 þ 2 78 þ 7
2 1 MVIIC 7.8 20 þ 3 18 þ 3
12 A6K 3.1 5 þ 3 18 þ 6
13 P7K 2.0 10 þ 3 31 þ 4
14 S17K 5.3 46 þ 6 17 þ 4
15 S19R 5.7 58 þ 3 18 þ 2
16 A6K, S17K 0.8 25 þ 4 22 þ 5
17 A6K, S19R 2.9 73 þ 7 57 þ 5
18 P7K, S17K 0.9 25 þ 1 6 þ 4
19 P7K, S19R 3.0 59 þ 1 18 þ 3
20 S17K, S19R 5.1 18 þ 1 31 þ 1
3 21 S19H 3.3 58 þ 3 32 þ 3
22 S19W 0.6 103 þ 7 51 þ 6
23 S17H, S19H 2.0 54 þ 3 10 þ 4
24 S17H, S19W 0.2 84 þ 1 28 þ 9
25 S17K, S19H 0.3 76 þ 3 16 þ 8
26 S19H, K25R 2.7 89 þ 1 24 þ 0
27 S19R, K25R 0.9 95 þ 8 15 þ 4
28 S19W, K25R 1.3 83 þ 4 15 þ 3
29 S17H, S19W, K25R 0.4 91 þ 6 34 þ 6
30 S17K, S19W, K25R 0.2 100 þ 5 24 þ 1
4 31 S17K, K25R 8.4 39 þ 5 14 þ 6
32 K4R, S17K, K25R 3.2 60 þ 5 5 þ 6
33 D14N, S17K, K25R 0.4 26 þ 9 8 þ 4
34 S17K, S19R, K25R 3.8 99 þ 2 8 þ 1
30 S17K, S19W, K25R 4.4 100 þ 5 24 þ 1
35 S17K, S19Y, K25R 4.5 52 þ 6 25 þ 5
36 K4R, S17K, S19R, K25R 1.5 103 þ 7 7 þ 0
37 K4R, S17K, S19W, K25R 1.2 94 þ 7 27 þ 8
38 K4R, S17K, S19Y, K25R 1.7 56 þ 4 20 þ 0
5 39 G-MVIIC 5.8 68 þ 3 45 þ 1
40 K-MVIIC 3.2 68 þ 1 26 þ 7
6 41 DG-MVIIC 1.0 100 þ 2 72 þ 2
42 KG-MVIIC 1.2 61 þ 7 32 þ 5
43 YG-MVIIC 0.6 64 þ 1 42 þ 2
44 DK-MVIIC 0.4 100 þ 0 80 þ 9
45 KK-MVIIC 0.9 89 þ 2 56 þ 4
46 YK-MVIIC 0.7 90 þ 2 82 þ 4
47 DN-MVIIC 0.5 97 þ 1 101 þ 2
48 KN-MVIIC 0.4 91 þ 7 61 þ 0
aCustomary names are as follows: K2Q is [Gln2]-MVIIC, and G-MVIIC and KG-MVIIC are glycyl-MVIIC and lysyl-glycyl-MVIIC, respec-
tively.
bThe value is calculated as the ratio of the weight of puri¢ed peptide to the theoretical weight calculated for the assembly on a peptide synthe-
sizer.
cBinding displacement of [125I]GVIA or [125I]MVIIC by 1037 M or 1038 M MVIIC and its analogues. The values represent means þ S.D.
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¢lter was washed twice with the ice-cold bu¡er used for diluting. In
both assays, binding was measured in triplicate and non-speci¢c bind-
ing was estimated by use of unlabeled GVIA or MVIIC at 1 WM as a
competitor.
2.4. NMR analysis
1H NMR spectra were measured at 288 K on a Bruker DRX-500
spectrometer operating at 500 MHz. The samples were prepared at a
concentration of 9 mM in 90% H2O/10% D2O at pH 4.0.
3. Results
3.1. Synthesis and puri¢cation of MVIIC analogues
We selected the residues to be replaced on the basis of
previous studies on the structure^activity relationship of
MVIIC. The sequence and substitutions are shown in Fig.
1. In run 1, three residues essential for activity, namely
Lys2, Met12, and Tyr13, were replaced with residues which
were expected to cause signi¢cant modulation of activity and
selectivity. In run 2 basic residues were substituted for resi-
dues which had not been identi¢ed as residues important for
activity in previous work [22]. Combinations of substitutions
in run 3 and run 4 were selected on the basis of the results
obtained in the assay of analogues from run 2. Replacements
of some charged residues, namely Lys4, Asp14, and Lys25,
were also incorporated in run 3 and run 4. Run 5 and run 6
were constructed for examining the e¡ects of elongation of the
N-terminus, based on the fact that the N-terminus of MVIIC
is exposed to the solvent in the solution structure determined
by NMR study.
The mixtures of protected linear precursors were synthe-
sized by usual Fmoc solid-phase methodology, and all the
possible precursors in each run were detected by HPLC and
mass analysis. The crude mixture of linear precursors was
subjected to oxidative disul¢de bond formation, a¡ording a
mixture of MVIIC analogues. The mixture contained many
kinds of impurities, which were also observed in the usual
preparation of a single analogue, i.e. polymers, disul¢de
bond isomers, and so on. The polymers were removed by
gel ¢ltration, then the monomers were separated by ion ex-
change chromatography into several groups and analyzed by
reversed-phase HPLC and MALDI-TOF-MS measurement.
Although disul¢de bond isomers of an analogue are indistin-
guishable from the analogue by mass analysis, we tentatively
assigned prominent peaks on HPLC pro¢les to the analogues
which had the same disul¢de bond pairings as MVIIC. A
pro¢le of the ion exchange chromatography and HPLC pro-
¢les of each fraction obtained in run 1 are shown in Fig. 2. All
the puri¢ed peptides, which are listed in Table 1, competed
with radiolabeled MVIIC at 1037 M, so that we regarded
them as MVIIC analogues, not isomers, because calcium
channels recognize conotoxins in highly rigorous mode and
it is unlikely that isomers bind to the channels speci¢cally.
Although the disul¢de bond pairings should be determined
for ¢nal con¢rmation, our purpose was to develop a blocker
more speci¢c than MVIIC, so that structural information was
obtained only for the most potent analogue.
The ratios of isolated analogues to the theoretical number
of analogues were 11/12, 10/16, 10/18, 9/16, 2/3 and 8/9 in runs
1^6 respectively. Among the excluded analogues, some were
not formed in su⁄cient amounts to be isolated and others
could not be adequately puri¢ed. For example, the replace-
ment of Asp14 with Asn appeared to prevent correct folding
and seven analogues which should contain Asn14 were not
isolated in run 4. In run 3 all the possible analogues seemed
to be formed su⁄ciently but eight analogues were concluded
to be inadequately puri¢ed, and were excluded. Finally we
could prepare MVIIC and 47 analogues from six runs, taking
duplication into account (Table 1).
3.2. Binding activities of MVIIC analogues to N- and P/Q-type
calcium channels
Binding activities of MVIIC and the 47 analogues to the N-
and P/Q-type calcium channels were estimated at 1038 M for
Fig. 1. The primary structure of MVIIC and the combinatorial re-
placement or elongation sites in MVIIC. The disul¢de bond pairings
are designated over the sequences.
Fig. 2. A: Ion exchange chromatography of the monomer fraction
obtained in run 1. The peptides were eluted from CM-cellulose CM-
52 (18U200 mm) in a gradient formed from 500 ml of 0.01 M am-
monium acetate bu¡er (pH 4.6) and 500 ml of 0.8 M ammonium
acetate bu¡er (pH 6.5). Fractions were combined into ¢ve groups
(F1^F5). B: Reversed-phase HPLC pro¢les of peptides in each com-
bined fraction. The peptides were eluted from an ODS column
(4.6U250 mm) in a linear gradient of 5^29% acetonitrile with aque-
ous 0.1% tri£uoroacetic acid for 24 min at a £ow rate of 1 ml/min.
The numbers above the peaks correspond to the analogue numbers
designated in Table 1.
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competition with radiolabeled MVIIC and at 1037 M for
competition with radiolabeled GVIA (Table 1). The analogues
obtained in run 1 generally showed lower a⁄nities than
MVIIC in both assays, while the e¡ect on selectivity varied.
For example, replacement of Tyr13 with Trp (in analogue 5)
decreased the a⁄nity more in competition with GVIA, where-
as replacement of Met12 with Thr (in analogue 3) decreased
the a⁄nity only in competition with MVIIC. In the case of the
analogues from run 2, a⁄nities were almost fully maintained,
especially in competition with MVIIC, and replacement of
Ser17 or Ser19 with a basic residue tended to increase selec-
tivity for P/Q-type channels (analogues 14 and 15). The e¡ects
of substitutions of Ser17 and Ser19 were further investigated
in run 3 and it was found that replacements of Ser19 with
basic or bulky residues decreased the a⁄nity for N-type chan-
nels. Replacement of Lys25 with Arg was also found to be
e¡ective for increasing selectivity for P/Q-type channels when
combined with replacements of Ser19. Elongation of the N-
terminus in runs 5 and 6 generally decreased a⁄nity for both
N- and P/Q type channels, but some analogues showed higher
selectivity for P/Q-type channels than MVIIC. We selected
analogues 34 in which Ser17, Ser19, and Lys25 were replaced
with Lys, Arg, and Arg respectively as a candidate P/Q-type
selective blocker because it showed the lowest a⁄nity for N-
type channels among the analogues which retained similar
a⁄nity to that of MVIIC for P/Q-type channels. The concen-
tration inhibition of [125I]GVIA or [125I]MVIIC binding rela-
tionship of analogue 34 is shown in Fig. 3, along with that of
analogue 3, which has decreased a⁄nity for P/Q-type and
retained a⁄nity for N-type channels.
3.3. NMR spectra
A preliminary NMR structural analysis of analogue 34
showed dispersion of NH chemical shifts, some of which
were preserved, while others deviated somewhat from those
of MVIIC (Fig. 4). The residues for which the NH chemical
shifts were well preserved are distributed mainly on L-strands,
whereas deviations are observed for residues in the other re-
gion.
4. Discussion
We wished to ¢nd MVIIC analogues with higher selectivity
for P/Q-type calcium channels than MVIIC, and obtained
some analogues which retained the a⁄nity for P/Q-type chan-
nels but exhibited decreased a⁄nity for N-type channels in
binding assay. Tyr13 is the most important residue for the
activity of GVIA, MVIIA, and MVIIC [14^18] and its re-
placement with Trp in MVIIC decreased the a⁄nity for
both channels, but the decrease was greater for N-type, so
that the selectivity for P/Q-type channels was increased. This
tendency, which was also noted by Nadasdi et al. [23], implies
that Trp13 is acceptable to P/Q-type calcium channels and
unfavorable to N-type channels, or that the contribution of
Tyr13 to the binding a⁄nity is relatively low for binding with
P/Q-type channels. The latter possibility is supported by our
previous work, which showed that recognition sites for bind-
ing with P/Q-type channels are spread over the whole mole-
cule [19]. The former possibility may be relevant to the e¡ect
of the replacement of Ser19 with Arg or Trp, which also
increased selectivity for P/Q-type channels. Ser19 is located
near Tyr13 in the solution structure so that its replacement
with residues possessing bulky side chains may have an e¡ect
comparable to that of replacement of Tyr13 with Trp.
The e¡ect of elongation at the N-terminus was studied in
runs 5 and 6 and it was revealed that elongation with two
residues was acceptable to some extent when Gly was intro-
duced as a spacer (analogues 42 and 43). This implies that the
channels may have some latitude around the N-terminus of
MVIIC or that the N-terminus may be located at an outer
vestibule of the channels, exposed to the solvent.
One of the important observations in this study is that
multiple substitutions showed unpredictable e¡ects on the ac-
tivity and selectivity. For example, Arg25 replacing Lys25
acted as an auxiliary to decrease a⁄nity for N-type channels
when combined with Arg19 replacing Ser19, but it had little
e¡ect when Ser17 was replaced with Lys. Such a result sug-
gests that further multiple substitutions would be helpful for
understanding the orientation of the whole molecule interact-
ing with the channels.
Fig. 3. Concentration^inhibition relationship of representative ana-
logues and MVIIC for [125I]GVIA or [125I]MVIIC binding to rat
cerebellar P2 membranes.
Fig. 4. Deviations of NH chemical shifts from MVIIC native values
in analogue 34. The residues which are located in L-strands in
MVIIC are designated by the bold lines.
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Recent studies on the structure^activity relationships of
g-conotoxins have revealed that some substitutions might
cause unexpected local conformational alteration in spite of
the rigid molecular sca¡old [18,24]. Taking up the question of
whether conformational alteration contributes to increased
selectivity, we sought structural information for analogue
34. Whereas the circular dichroism spectrum of analogue 34
was similar to that of MVIIC (data not shown), some devia-
tions of NH chemical shifts were observed in NMR analysis
(Fig. 4). Although analogue 34 seems to retain the canonical
structure of g-conotoxins, the local conformational changes
may in£uence the activity and selectivity, as well as the sub-
stituted side chains.
In this work, we succeeded in preparing MVIIC and 47
analogues in only six runs by use of a combinatorial method,
which was developed from the ordinary chemical synthesis
method for MVIIC. The amount of each obtained analogue
was inevitably smaller than that of an individually synthesized
analogue, but was su⁄cient for identi¢cation and estimation
of activities, and no tendency for increased polymerization or
aggregation was observed in comparison with a single ana-
logue preparation. The most important factor which made
this method feasible is that the method for preparing a single
MVIIC analogue has been well established in terms of oxida-
tive folding conditions and puri¢cation method.
The simultaneous disul¢de bond formation method de-
scribed here is still at a preliminary stage and technical im-
provements are necessary for its application to the prepara-
tion of peptide libraries. However, we believe it has
considerable potential for the discovery of ion channel block-
ers with higher a⁄nity and selectivity. Moreover, it should be
applicable for creating functional molecules other than ion
channel blockers, for example, molecules which modulate pro-
tein^protein interaction. Such a strategy should help us to
develop many types of pharmacological tools and lead mole-
cules for drug design.
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